dc.contributor.author | Hall, E | |
dc.contributor.author | Hague, C | |
dc.contributor.author | Foran, B | |
dc.contributor.author | Guild, S | |
dc.contributor.author | Joseph, O | |
dc.contributor.author | Moule, R | |
dc.contributor.author | Nutting, C | |
dc.contributor.author | Parsons, S | |
dc.contributor.author | Prestwich, R | |
dc.contributor.author | Slevin, N | |
dc.contributor.author | West, C | |
dc.contributor.author | Thomson, D | |
dc.date.accessioned | 2021-01-08T15:05:18Z | |
dc.identifier.citation | Clinical Oncology | |
dc.identifier.issn | 0936-6555 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4268 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.title | Patient involvement in the design of a phase III trial comparing IMPT and IMRT for oropharyngeal cancer | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2018-01-30 | |
rioxxterms.licenseref.startdate | 2018-01-30 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Clinical Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/ICR-CTSU Urology and Head and Neck Trials Team | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/ICR-CTSU Urology and Head and Neck Trials Team | |
pubs.embargo.terms | Not known | |
icr.researchteam | ICR-CTSU Urology and Head and Neck Trials Team | en_US |
dc.contributor.icrauthor | Hall, Emma | en |